3E0130M ICD-10-PCS Code: Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
Introduction of Antneo, Moncln Ab, into Subcu, Perc Approach
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | Section3 | Administration |
| 2 | Body SystemE | Physiological Systems and Anatomical Regions |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body System / Region1 | Subcutaneous Tissue |
| 5 | Approach3 | Percutaneous |
| 6 | Substance0 | Antineoplastic |
| 7 | QualifierM | Monoclonal Antibody |
Related Codes
Same operation — other Body System / Region
Same table and root operation, differing only in the body system / region character.
3E0230M — Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach, 3E0330M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach, 3E0430M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach, 3E0530M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach, 3E0630M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach, 3E0930M — Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach, 3E0A30M — Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach, 3E0B30M — Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach, +19 more
Same operation — other Qualifier
Same table and root operation, differing only in the qualifier character.
3E01305 — Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
Same procedure category (CCSR), other tables
AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Chemotherapy (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.
XW01318 — Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8, XW01329 — Introduction of Talquetamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9, XW01348 — Introduction of Teclistamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8, XW013L9 — Introduction of Elranatamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9, XW013S9 — Introduction of Epcoritamab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9, XW03358 — Introduction of Mosunetuzumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW03368 — Introduction of Afamitresgene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW03378 — Introduction of Tabelecleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW03387 — Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW03388 — Introduction of Treosulfan into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW0338A — Introduction of Obecabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW0339A — Introduction of Odronextamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033A7 — Introduction of Ciltacabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033B3 — Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 3, XW033B7 — Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033BA — Introduction of Orca-T Allogeneic T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033C7 — Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033CA — Introduction of Zanidatamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033G7 — Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033H7 — Introduction of Axicabtagene Ciloleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7, +40 more
Contextual Map
Every relationship of 3E0130M in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
PCS table
- 3E0[PCS table]— CMS ICD-10-PCS tables
- Administration — Section: Administration[Section]: “Administration”— CMS ICD-10-PCS tables
- Physiological Systems and Anatomical Regions — Body System: Physiological Systems and Anatomical Regions[Body System]: “Physiological Systems and Anatomical Regions”— CMS ICD-10-PCS tables
- Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables
Clinical classification (CCSR)
- ADM012 — Chemotherapy[CCSR category]: “Chemotherapy — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1
Nearest codes
- 3E01305 — Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0230M — Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0330M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0430M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0530M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0630M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0930M — Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0A30M — Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
Change history
No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.
Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels